USPTOSchützen Sie diese Marke vor Nachahmern!
Mit unserer Markenüberwachung werden Sie automatisch per E-Mail über Nachahmer und Trittbrettfahrer benachrichtigt.
Die US-Marke MIRROR IMAGE wurde als Wortmarke am 17.09.2001 beim Amerikanischen Patent- und Markenamt angemeldet.
Sie wurde am 11.03.2003 im Markenregister eingetragen.
Der aktuelle Status der Marke ist "CANCELLED - SECTION 8".
| Markenform | Wortmarke |
| Aktenzeichen | 76313158 |
| Registernummer | 2694903 |
| Anmeldedatum | 17. September 2001 |
| Veröffentlichungsdatum | 17. Dezember 2002 |
| Eintragungsdatum | 11. März 2003 |
Markeninhaber
Gustav-Meyer Allee 25
13355 Berlin
DE
13355 Berlin
DE
Markenvertreter
Waren und Dienstleistungen
1
Chemical products, namely polynucleotides, preferably containing at least one L-nucleotide, polypeptides, preferably containing at least one D-amino acid, compounds consisting in whole or in part of nucleic acids or derivatives thereof, for industrial, scientific, agricultural, gardening and forestry purposes; D- and L- nucleotides for use in manufacturing pharmaceuticals; L- and D- amino acids for use in manufacturing pharmaceuticals
5
Pharmaceutical and veterinary products, namely, preparations for sanitation, slimming, appetite suppressants, pharmaceuticals for acidosis therapeutics, analeptic and antihypoxaemics; analgetics and antirheumatic drugs, pharmaceuticals functioning as antihelmintics, antiallergics, antianemia drugs, antiarrhythmics, antibiotics and antiinfectives, antidementics, nootropics, antidiabetics, antidotes for the treatment of poisoning, antiemetics and antivertiginosics, antiepileptics, antihemorrhagics, antifibrinolyrics, hemostatics, antihypertonics, antihypoglycemics, antihypotonics, anticoagulants, antimycotics, pharmaceuticals functioning as antiparasitics, antiphlogistics, antitussives, expectorants for use in atherosclerosis, balneotherapeutics and pharmaceuticals for thermal therapy, pharmaceuticals functioning as beta receptor blocking agents, pharmaceuticals for calcium channel blocking and inhibiting of the renin angiotensin-system, pharmaceuticals functioning as broncholytics and antiasthmetics cholagoguegics and for use in biliary tract therapeutics; pharmaceuticals functioning as cholinergics, corticoids, dermatics; all purpose disinfectants and antiseptics; pharmaceuticals functioning as dietetic agents and in alimentary therapeutics; diagnostic preparations functioning as diuretics, as agents for favoring blood flow, as withdrawal agents, as fibrinolytics, to treat gout, the flu and catarrhal fever; pharmaceuticals for the treatment of gynecological illnesses, namely, menstrual cramps, hemorrhoids, hepatitis; pharmaceuticals functioning as hypnotics and sedatives; pharmaceuticals to treat cardiac ailments; pharmaceuticals for use in caries and parodontosis; dental preparations, namely, dental abrasives; laxatives, pharmaceuticals functioning as antilipaemics, local anaesthetics, neural therapeutics, gastro-intestinal preparations, pharmaceuticals to treat migraines; pharmaceutical preparations for use in mouth and pharyngeal therapeutics; pharmaceuticals for use as muscle relaxants; pharmaceuticals for the treatment of addiction to narcotics; pharmaceuticals for use in neuropathology; ophthalmic pharmaceuticals for treating blindness, conjunctivitis, cataract, glaucoma, retinal detachment, stye, chalazion, dacryoadenitis, corneal clouding, keratitis, gasserian ganglionitis, vitreous opacity, amaurosis, retinopathy, central retinal artery occlusion, retinoblastoma, melanoma, optic neuritis, optic nerve atrophy; pharmaceuticals for use osteoporosis and calcium metabolism modification; pharmaceuticals for the treatment of Parkinson's Disease and disturbances of the extrapyramidal system; pharmaceuticals for psychotropic, rhinologic and sinositic purposes; pharmaceuticals functioning as roborants and tonics; pharmaceuticals for use in thyroidal therapeutics; pharmaceuticals functioning as spasmolytics and inhibitors of thrombocyte aggregation; pharmaceuticals for the treatment of tuberculosis; pharmaceuticals functioning as alternants, urologics and venous agents; vitamins; pharmaceuticals for use as cytostatics and antineoplastic agents; homeopathic remedies, and medical plastics, namely sanitary preparations
9
Scientific, electronic, photographic, optical, measuring, signaling and controlling apparatus and instruments, namely, analytical devices comprising polynucleotides, polypeptides or polynucleotides and polypeptides as detection means; magnetic data medium, namely tapes, discs, diskettes and CDs, preferably containing sequence data on polynucleotides, polypeptides or polynucleotides and polypeptides; computers; computer software for designing target specific polynucleotides and polypeptides and software for use in the field of synthesis of nucleic acids and peptides, proteins and control of synthesis machines
42
Research and product development services for others in the filed of veterinary medicine, human medicine and agriculture; research and product development for others in the science and medical industries; computer services, namely, designing programs for others in data processing; chemistry consultation; biology consultation; biochemistry consultation; biotechnology consultation; gene technologies consultation; molecular biology consultation; pharmaceutical advice; medical services, veterinary services
Die Bezeichnungen wurden automatisch übersetzt. Übersetzung anzeigen
ID: 1376313158